At a Glance
Dosage
oral
| Level | 1cP-MiPLA | 1B-LSD |
|---|---|---|
| Threshold | 50 µg | 15 µg |
| Light | 100–150 µg | 25–75 µg |
| Common | 150–200 µg | 75–150 µg |
| Strong | 200–250 µg | 150–300 µg |
| Heavy | 300 µg | 300 µg |
Duration
oral
1cP-MiPLA
oral
Total: 4 hrs – 6 hrsCome Up
Peak
Offset
Onset20 min – 40 min
Come Up45 min – 1.5 hrs
Peak1 hrs – 2 hrs
Offset1 hrs – 2 hrs
1B-LSD
Effects
Safety
Interaction: 1cP-MiPLA + 1B-LSD
No direct interaction data available between these substances. This does not mean the combination is safe.
1cP-MiPLA — Dangerous Interactions
No dangerous interactions recorded.
1B-LSD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 1cP-MiPLA and 1B-LSD?
1cP-MiPLA is classified as a Psychedelic (Lysergamides) while 1B-LSD is classified as a Psychedelic (Lysergamides). They share 64 effects in common, with 6 effects unique to 1cP-MiPLA and 15 unique to 1B-LSD.
Is it safe to combine 1cP-MiPLA and 1B-LSD?
There is no direct interaction data available for combining 1cP-MiPLA and 1B-LSD. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 1cP-MiPLA or 1B-LSD?
At common doses via oral, 1cP-MiPLA is typically dosed at 150–200 µg while 1B-LSD is dosed at 75–150 µg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.